Nanospectra Biosciences Names Michael Brawer, M.D. as Chief Medical Officer
HOUSTON, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, today announced the appointment of Michael Brawer, M.D., as ... Devices, Oncology, Urology, Personnel Nanospectra Biosciences, nanomedicine, AuroLase, thermal ablation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Marketing | Medical Devices | Nanotechnology | Pharmaceuticals | Urology & Nephrology